Revocation of life sciences patents in the UPC
2025年6月17日
Lydia is a senior counsel in the Patents team in our London office and has a depth of knowledge and experience in both the Life Sciences & Healthcare, and Technology, Media and Communications sectors.
Lydia has a broad practice, advising clients on international strategy in relation to telecommunications and tech, medical device and pharmaceutical patent litigation. In particular she has represented clients in many of the leading cases involving SEP and FRAND matters.
Lydia has litigated in the High Court and Court of Appeal, co-ordinated multi-jurisdictional disputes and advised on EPO opposition proceedings. She has also advised on and co-ordinated the first ever case to be heard in the Nordic-Baltic Regional Division of the Unified Patent Court.
Lydia's clients include leading international telecommunication companies, and global pharmaceutical and medical device companies.
最新新闻和观点
Patent Perspectives Quick Listens
点击此处了解更多
Episode 7 - Obtaining documentary evidence in the UPC - a look at Rule 190 of the Rules of Procedure
In this episode Paul England is joined by Lydia Birch, Anja Lunze and Michael Washbrook
2025年4月15日
4 / 10 播客
